1 asset in Appendiceal Neoplasm
Therapeutic assets addressing Appendiceal Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nilotinib Appendiceal Neoplasm | National Cancer Institute (NCI) | P2 | B (57) |
Therapeutic assets addressing Appendiceal Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nilotinib Appendiceal Neoplasm | National Cancer Institute (NCI) | P2 | B (57) |